Literature DB >> 21637912

Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.

Alpha Mu Nurul-Syakima1, C Yoke-Kqueen, A R Sabariah, M S Shiran, A Singh, L Learn-Han.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that involved in various cancer-related cellular processes. Diverse studies on expression profiling of miRNAs have been performed and the data showed that some miRNAs are up-regulated or down-regulated in cancer. Until now, there are no data published on the miRNA expression in head and neck cancers from Malaysia. Hence, this study aimed to investigate potentially crucial miRNAs in head and neck cancer patients from Malaysian populations. A global miRNA profiling was performed on 12 samples of head and neck cancer tissue using microarray analysis followed by validation using real-time RT-PCR. Microarray analysis identified 10 miRNAs that could distinguish malignant head and neck cancer lesions from normal tissues; 7 miRNAs (hsa-miR-181a-2*, hsa-miR-29b-1*, hsa-miR-181a, hsa-miR-181b, hsa-miR-744, hsa-miR-1271 and hsa-miR-221*) were up-regulated while 3 miRNAs (hsa-miR-141, hsa-miR-95 and hsa-miR-101) were down-regulated. These miRNAs may contribute in a simple profiling strategy to identify individuals at higher risk of developing head and neck cancers, thus helping in the elucidation of the molecular mechanisms involved in head and neck cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21637912     DOI: 10.3892/ijmm.2011.714

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  29 in total

1.  miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis.

Authors:  Haitao Bai; Zhongwei Cao; Chong Deng; Lili Zhou; Chun Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-01       Impact factor: 4.553

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

3.  The expression profiles of microRNAs in Kaposi's sarcoma.

Authors:  Xiu-Juan Wu; Xiong-Ming Pu; Zong-Feng Zhao; Ya-Nan Zhao; Xiao-Jing Kang; Wei-Dong Wu; Yun-Min Zou; Cao-Ying Wu; Yuan-Yuan Qu; De-Zhi Zhang; Yan-Yan Feng; Jian-Yong Liu
Journal:  Tumour Biol       Date:  2014-10-01

4.  The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer.

Authors:  Alireza Andalib; Shadi Rashed; Moein Dehbashi; Jamshid Hajati; Farshid Noorbakhsh; Mazdak Ganjalikhani-Hakemi
Journal:  Indian J Clin Biochem       Date:  2019-03-21

5.  Analysis of circulating microRNAs in adrenocortical tumors.

Authors:  Diana Rita Szabó; Michaela Luconi; Peter M Szabó; Miklós Tóth; Nikolette Szücs; János Horányi; Zoltán Nagy; Massimo Mannelli; Attila Patócs; Károly Rácz; Peter Igaz
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

Review 6.  Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.

Authors:  R Ranjha; J Paul
Journal:  Inflamm Res       Date:  2013-02-17       Impact factor: 4.575

7.  MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5.

Authors:  Kumsal Ayse Tekirdag; Gozde Korkmaz; Deniz Gulfem Ozturk; Reuven Agami; Devrim Gozuacik
Journal:  Autophagy       Date:  2013-01-15       Impact factor: 16.016

8.  miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review).

Authors:  Juan Liu; Weifeng Shi; Changping Wu; Jingfang Ju; Jingting Jiang
Journal:  Biomed Rep       Date:  2013-11-07

9.  Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinoma.

Authors:  Qingsong Yu; Fangrong Zhang; Zhengde Du; Yi Xiang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

10.  MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.

Authors:  Xiao-Yu Liu; Zhi-Jian Liu; Hong He; Chen Zhang; Yun-Long Wang
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.